Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 640

1.

Reconceiving bioethical proceduralism: an ontological perspective.

Taylor MD.

Cuad Bioet. 2019 May-Aug;30(99):135-147. doi: 10.30444/CB.28.

2.

Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis.

Huang M, Tailor J, Zhen Q, Gillmor AH, Miller ML, Weishaupt H, Chen J, Zheng T, Nash EK, McHenry LK, An Z, Ye F, Takashima Y, Clarke J, Ayetey H, Cavalli FMG, Luu B, Moriarity BS, Ilkhanizadeh S, Chavez L, Yu C, Kurian KM, Magnaldo T, Sevenet N, Koch P, Pollard SM, Dirks P, Snyder MP, Largaespada DA, Cho YJ, Phillips JJ, Swartling FJ, Morrissy AS, Kool M, Pfister SM, Taylor MD, Smith A, Weiss WA.

Cell Stem Cell. 2019 Jun 11. pii: S1934-5909(19)30217-6. doi: 10.1016/j.stem.2019.05.013. [Epub ahead of print]

3.

Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.

Park AK, Lee JY, Cheong H, Ramaswamy V, Park SH, Kool M, Phi JH, Choi SA, Cavalli F, Taylor MD, Kim SK.

BMC Cancer. 2019 Jun 11;19(1):571. doi: 10.1186/s12885-019-5742-x.

4.

Anatomical predictors of conduction damage after transcatheter implantation of the aortic valve.

Tretter JT, Mori S, Anderson RH, Taylor MD, Ollberding N, Truong V, Choo J, Kereiakes D, Mazur W.

Open Heart. 2019 Apr 9;6(1):e000972. doi: 10.1136/openhrt-2018-000972. eCollection 2019.

5.

The Impact of Minimally Invasive Gastrectomy on Survival in the USA.

Hendriksen BS, Brooks AJ, Hollenbeak CS, Taylor MD, Reed MF, Soybel DI.

J Gastrointest Surg. 2019 May 31. doi: 10.1007/s11605-019-04263-4. [Epub ahead of print]

PMID:
31152343
6.

Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'.

Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, Merchant M, Pfister SM, Pollard SM, Ramaswamy V, Rich JN, Robinson GW, Rowitch DH, Sampson JH, Taylor MD, Workman P, Gilbertson RJ.

Nat Rev Clin Oncol. 2019 May 31. doi: 10.1038/s41571-019-0236-y. [Epub ahead of print] No abstract available.

PMID:
31150022
7.

Commentary: An unusual case of crossing coronaries.

Taylor MD.

J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30925-0. doi: 10.1016/j.jtcvs.2019.04.030. [Epub ahead of print] No abstract available.

PMID:
31126642
8.

Perioperative chemotherapy is not associated with improved survival in stage I pleomorphic lung cancer.

Hendriksen BS, Hollenbeak CS, Reed MF, Taylor MD.

J Thorac Cardiovasc Surg. 2019 Apr 17. pii: S0022-5223(19)30824-4. doi: 10.1016/j.jtcvs.2019.04.005. [Epub ahead of print]

PMID:
31122617
9.

Minimally Invasive Lobectomy Modality and Other Predictors of Conversion to Thoracotomy.

Hendriksen BS, Hollenbeak CS, Taylor MD, Reed MF.

Innovations (Phila). 2019 May 17:1556984519849037. doi: 10.1177/1556984519849037. [Epub ahead of print]

PMID:
31099278
10.

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.

Sharma T, Schwalbe EC, Williamson D, Sill M, Hovestadt V, Mynarek M, Rutkowski S, Robinson GW, Gajjar A, Cavalli F, Ramaswamy V, Taylor MD, Lindsey JC, Hill RM, Jäger N, Korshunov A, Hicks D, Bailey S, Kool M, Chavez L, Northcott PA, Pfister SM, Clifford SC.

Acta Neuropathol. 2019 May 10. doi: 10.1007/s00401-019-02020-0. [Epub ahead of print]

PMID:
31076851
11.

Childhood cerebellar tumours mirror conserved fetal transcriptional programs.

Vladoiu MC, El-Hamamy I, Donovan LK, Farooq H, Holgado BL, Sundaravadanam Y, Ramaswamy V, Hendrikse LD, Kumar S, Mack SC, Lee JJY, Fong V, Juraschka K, Przelicki D, Michealraj A, Skowron P, Luu B, Suzuki H, Morrissy AS, Cavalli FMG, Garzia L, Daniels C, Wu X, Qazi MA, Singh SK, Chan JA, Marra MA, Malkin D, Dirks P, Heisler L, Pugh T, Ng K, Notta F, Thompson EM, Kleinman CL, Joyner AL, Jabado N, Stein L, Taylor MD.

Nature. 2019 May 1. doi: 10.1038/s41586-019-1158-7. [Epub ahead of print]

PMID:
31043743
12.

Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.

Grewal JK, Tessier-Cloutier B, Jones M, Gakkhar S, Ma Y, Moore R, Mungall AJ, Zhao Y, Taylor MD, Gelmon K, Lim H, Renouf D, Laskin J, Marra M, Yip S, Jones SJM.

JAMA Netw Open. 2019 Apr 5;2(4):e192597. doi: 10.1001/jamanetworkopen.2019.2597.

13.

Updating physiologically based pharmacokinetic models for manganese by incorporating rapid association/dissociation processes in tissues.

Yoon M, Efremenko A, Van Landingham C, Gentry PR, Keene AM, Taylor MD, Clewell HJ, Andersen ME.

Toxicol Appl Pharmacol. 2019 Jun 1;372:1-10. doi: 10.1016/j.taap.2019.04.006. Epub 2019 Apr 9.

14.

Design and development of the Hypoglycaemia Symptom Rating Questionnaire (HypoSRQ).

Taylor MD, Han TS, Ward H, Bradley C.

Diabetes Res Clin Pract. 2019 May;151:187-197. doi: 10.1016/j.diabres.2019.04.010. Epub 2019 Apr 5.

PMID:
30959150
15.

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.

Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, Price AJ, De Mello RA, Dias JS, Huntsman D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U.

J Clin Invest. 2019 Apr 1;129(4):1801. doi: 10.1172/JCI128527. Epub 2019 Apr 1. No abstract available.

16.

Do conventional cooking methods alter concentrations of per- and polyfluoroalkyl substances (PFASs) in seafood?

Taylor MD, Nilsson S, Bräunig J, Bowles KC, Cole V, Moltschaniwskyj NA, Mueller JF.

Food Chem Toxicol. 2019 May;127:280-287. doi: 10.1016/j.fct.2019.03.032. Epub 2019 Mar 21.

PMID:
30905867
17.

Assessment of liver T1 mapping in fontan patients and its correlation with magnetic resonance elastography-derived liver stiffness.

Ramachandran P, Serai SD, Veldtman GR, Lang SM, Mazur W, Trout AT, Dillman JR, Fleck RJ, Taylor MD, Alsaied T, Moore RA.

Abdom Radiol (NY). 2019 Jul;44(7):2403-2408. doi: 10.1007/s00261-019-01990-9.

PMID:
30903232
18.

Picosecond Infrared Laser Desorption Mass Spectrometry Identifies Medulloblastoma Subgroups on Intrasurgical Timescales.

Woolman M, Kuzan-Fischer CM, Ferry I, Kiyota T, Luu B, Wu M, Munoz DG, Das S, Aman A, Taylor MD, Rutka JT, Ginsberg HJ, Zarrine-Afsar A.

Cancer Res. 2019 May 1;79(9):2426-2434. doi: 10.1158/0008-5472.CAN-18-3411. Epub 2019 Mar 19.

PMID:
30890619
19.

Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.

Wang J, Merino DM, Light N, Murphy BL, Wang YD, Guo X, Hodges AP, Chau LQ, Liu KW, Dhall G, Asgharzadeh S, Kiehna EN, Shirey RJ, Janda KD, Taylor MD, Malkin D, Ellison DW, VandenBerg SR, Eberhart CG, Sears RC, Roussel MF, Gilbertson RJ, Wechsler-Reya RJ.

Cancer Res. 2019 May 1;79(9):2208-2219. doi: 10.1158/0008-5472.CAN-18-2565. Epub 2019 Mar 18.

PMID:
30885981
20.

Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma.

Hoffman M, Gillmor AH, Kunz DJ, Johnston MJ, Nikolic A, Narta K, Zarrei M, King J, Ellestad K, Dang NH, Cavalli FMG, Kushida MM, Coutinho FJ, Zhu Y, Luu B, Ma Y, Mungall AJ, Moore R, Marra MA, Taylor MD, Pugh TJ, Dirks PB, Strother D, Lafay-Cousin L, Resnick AC, Scherer S, Senger DL, Simons BD, Chan JA, Morrissy AS, Gallo M.

Cancer Res. 2019 May 1;79(9):2111-2123. doi: 10.1158/0008-5472.CAN-18-3441. Epub 2019 Mar 15.

PMID:
30877103
21.

An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database.

Carrigan G, Whipple S, Taylor MD, Torres AZ, Gossai A, Arnieri B, Tucker M, Hofmeister PP, Lambert P, Griffith SD, Capra WB.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):572-581. doi: 10.1002/pds.4758. Epub 2019 Mar 14.

PMID:
30873729
22.

Abnormal submaximal cardiopulmonary exercise parameters predict impaired peak exercise performance in sickle cell anemia patients.

Powell AW, Alsaied T, Niss O, Fleck RJ, Malik P, Quinn CT, Mays WA, Taylor MD, Chin C.

Pediatr Blood Cancer. 2019 Jun;66(6):e27703. doi: 10.1002/pbc.27703. Epub 2019 Mar 7.

PMID:
30848046
23.

Retraction Note: A homing system targets therapeutic T cells to brain cancer.

Samaha H, Pignata A, Fousek K, Ren J, Lam FW, Stossi F, Dubrulle J, Salsman VS, Krishnan S, Hong SH, Baker ML, Shree A, Gad AZ, Shum T, Fukumura D, Byrd TT, Mukherjee M, Marrelli SP, Orange JS, Joseph SK, Sorensen PH, Taylor MD, Hegde M, Mamonkin M, Jain RK, El-Naggar S, Ahmed N.

Nature. 2019 Mar;567(7746):132. doi: 10.1038/s41586-019-0967-z.

24.

Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth.

Fults DW, Taylor MD, Garzia L.

J Neurosurg Pediatr. 2019 Feb 15:1-9. doi: 10.3171/2018.11.PEDS18506. [Epub ahead of print] Review.

PMID:
30771762
25.

Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost.

Zapotocky M, Beera K, Adamski J, Laperierre N, Guger S, Janzen L, Lassaletta A, Figueiredo Nobre L, Bartels U, Tabori U, Hawkins C, Urbach S, Tsang DS, Dirks PB, Taylor MD, Bouffet E, Mabbott DJ, Ramaswamy V.

Cancer. 2019 Jun 1;125(11):1867-1876. doi: 10.1002/cncr.31995. Epub 2019 Feb 15.

PMID:
30768777
26.

Medulloblastoma.

Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM.

Nat Rev Dis Primers. 2019 Feb 14;5(1):11. doi: 10.1038/s41572-019-0063-6. Review.

PMID:
30765705
27.

Treatment exposures stratify need for echocardiographic screening in asymptomatic long-term survivors of hematopoietic stem cell transplantation.

Rotz SJ, Powell A, Myers KC, Taylor MD, Jefferies JL, Lane A, El-Bietar JA, Davies SM, Dandoy CE, Ryan TD.

Cardiol Young. 2019 Mar;29(3):338-343. doi: 10.1017/S104795111800238X. Epub 2019 Feb 12.

PMID:
30744727
28.

Challenges to curing primary brain tumours.

Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, Merchant M, Pfister SM, Pollard SM, Ramaswamy V, Rich JN, Robinson GW, Rowitch DH, Sampson JH, Taylor MD, Workman P, Gilbertson RJ.

Nat Rev Clin Oncol. 2019 Feb 7. doi: 10.1038/s41571-019-0177-5. [Epub ahead of print] Review.

PMID:
30733593
29.

Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death.

Kallay L, Keskin H, Ross A, Rupji M, Moody OA, Wang X, Li G, Ahmed T, Rashid F, Stephen MR, Cottrill KA, Nuckols TA, Xu M, Martinson DE, Tranghese F, Pei Y, Cook JM, Kowalski J, Taylor MD, Jenkins A, Pomeranz Krummel DA, Sengupta S.

J Neurooncol. 2019 May;142(3):411-422. doi: 10.1007/s11060-019-03115-0. Epub 2019 Feb 6.

30.

Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.

Beckmann PJ, Larson JD, Larsson AT, Ostergaard JP, Wagner S, Rahrmann EP, Shamsan GA, Otto GM, Williams RL, Wang J, Lee C, Tschida BR, Das P, Dubuc AM, Moriarity BS, Picard D, Wu X, Rodriguez FJ, Rosemarie Q, Krebs RD, Molan AM, Demer AM, Frees MM, Rizzardi AE, Schmechel SC, Eberhart CG, Jenkins RB, Wechsler-Reya RJ, Odde DJ, Huang A, Taylor MD, Sarver AL, Largaespada DA.

Cancer Res. 2019 Mar 1;79(5):905-917. doi: 10.1158/0008-5472.CAN-18-1261. Epub 2019 Jan 23.

PMID:
30674530
31.

Lytic Therapy for Retained Traumatic Hemothorax: A Systematic Review and Meta-analysis.

Hendriksen BS, Kuroki MT, Armen SB, Reed MF, Taylor MD, Hollenbeak CS.

Chest. 2019 Apr;155(4):805-815. doi: 10.1016/j.chest.2019.01.007. Epub 2019 Jan 18.

PMID:
30664856
32.

Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells.

Robson JP, Remke M, Kool M, Julian E, Korshunov A, Pfister SM, Osborne GW, Taylor MD, Wainwright B, Reynolds BA.

PLoS One. 2019 Jan 18;14(1):e0210665. doi: 10.1371/journal.pone.0210665. eCollection 2019.

33.

PPAR and GST polymorphisms may predict changes in intellectual functioning in medulloblastoma survivors.

Oyefiade A, Erdman L, Goldenberg A, Malkin D, Bouffet E, Taylor MD, Ramaswamy V, Scantlebury N, Law N, Mabbott DJ.

J Neurooncol. 2019 Mar;142(1):39-48. doi: 10.1007/s11060-018-03083-x. Epub 2019 Jan 3.

PMID:
30607709
34.

A functional genomics approach to identify pathways of drug resistance in medulloblastoma.

Bertrand KC, Faria CC, Skowron P, Luck A, Garzia L, Wu X, Agnihotri S, Smith CA, Taylor MD, Mack SC, Rutka JT.

Acta Neuropathol Commun. 2018 Dec 27;6(1):146. doi: 10.1186/s40478-018-0652-8. No abstract available.

35.

Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma.

Yin WC, Satkunendran T, Mo R, Morrissy S, Zhang X, Huang ES, Uusküla-Reimand L, Hou H, Son JE, Liu W, Liu YC, Zhang J, Parker J, Wang X, Farooq H, Selvadurai H, Chen X, Sau-Wai Ngan E, Cheng SY, Dirks PB, Angers S, Wilson MD, Taylor MD, Hui CC.

Dev Cell. 2019 Jan 28;48(2):167-183.e5. doi: 10.1016/j.devcel.2018.11.015. Epub 2018 Dec 13.

PMID:
30554998
36.

MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.

Iv M, Zhou M, Shpanskaya K, Perreault S, Wang Z, Tranvinh E, Lanzman B, Vajapeyam S, Vitanza NA, Fisher PG, Cho YJ, Laughlin S, Ramaswamy V, Taylor MD, Cheshier SH, Grant GA, Young Poussaint T, Gevaert O, Yeom KW.

AJNR Am J Neuroradiol. 2019 Jan;40(1):154-161. doi: 10.3174/ajnr.A5899. Epub 2018 Dec 6.

PMID:
30523141
37.

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.

Fukuoka K, Kanemura Y, Shofuda T, Fukushima S, Yamashita S, Narushima D, Kato M, Honda-Kitahara M, Ichikawa H, Kohno T, Sasaki A, Hirato J, Hirose T, Komori T, Satomi K, Yoshida A, Yamasaki K, Nakano Y, Takada A, Nakamura T, Takami H, Matsushita Y, Suzuki T, Nakamura H, Makino K, Sonoda Y, Saito R, Tominaga T, Matsusaka Y, Kobayashi K, Nagane M, Furuta T, Nakada M, Narita Y, Hirose Y, Ohba S, Wada A, Shimizu K, Kurozumi K, Date I, Fukai J, Miyairi Y, Kagawa N, Kawamura A, Yoshida M, Nishida N, Wataya T, Yamaoka M, Tsuyuguchi N, Uda T, Takahashi M, Nakano Y, Akai T, Izumoto S, Nonaka M, Yoshifuji K, Kodama Y, Mano M, Ozawa T, Ramaswamy V, Taylor MD, Ushijima T, Shibui S, Yamasaki M, Arai H, Sakamoto H, Nishikawa R, Ichimura K; Japan Pediatric Molecular Neuro-Oncology Group (JPMNG).

Acta Neuropathol Commun. 2018 Dec 4;6(1):134. doi: 10.1186/s40478-018-0630-1.

38.

The influence of depth and a subsea pipeline on fish assemblages and commercially fished species.

Bond T, Partridge JC, Taylor MD, Cooper TF, McLean DL.

PLoS One. 2018 Nov 26;13(11):e0207703. doi: 10.1371/journal.pone.0207703. eCollection 2018.

39.

Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial.

Sandberg DI, Yu B, Patel R, Hagan J, Miesner E, Sabin J, Smith S, Fletcher S, Shah MN, Sirianni RW, Taylor MD.

J Neurooncol. 2019 Jan;141(2):449-457. doi: 10.1007/s11060-018-03055-1. Epub 2018 Nov 20.

PMID:
30460634
40.

Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.

Tsang DS, Murray L, Ramaswamy V, Zapotocky M, Tabori U, Bartels U, Huang A, Dirks PB, Taylor MD, Hawkins C, Bouffet E, Laperriere N.

Neuro Oncol. 2019 Mar 18;21(4):547-557. doi: 10.1093/neuonc/noy191.

PMID:
30452715
41.

Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.

Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, Li G, Wechsler-Reya RJ, Reimand J, Cho YJ, Taylor MD, Weissman IL, Mitra SS, Cheshier SH.

Nat Commun. 2018 Nov 2;9(1):4651. doi: 10.1038/s41467-018-07182-1.

42.

Survey design for quantifying perfluoroalkyl acid concentrations in fish, prawns and crabs to assess human health risks.

Taylor MD.

Sci Total Environ. 2019 Feb 20;652:59-65. doi: 10.1016/j.scitotenv.2018.10.117. Epub 2018 Oct 10.

PMID:
30359802
43.

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.

Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, Price AJ, De Mello RA, Dias JS, Huntsman D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U.

J Clin Invest. 2019 Jan 2;129(1):223-229. doi: 10.1172/JCI121303. Epub 2018 Dec 3. Erratum in: J Clin Invest. 2019 Apr 1;129(4):1801.

44.

How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma.

Khakban A, Mohammadi T, Lynd LD, Mabbott DJ, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor MD, Marra CA.

Patient Prefer Adherence. 2018 Oct 10;12:2103-2110. doi: 10.2147/PPA.S168739. eCollection 2018.

45.

BMI1 is a therapeutic target in recurrent medulloblastoma.

Bakhshinyan D, Venugopal C, Adile AA, Garg N, Manoranjan B, Hallett R, Wang X, Mahendram S, Vora P, Vijayakumar T, Subapanditha M, Singh M, Kameda-Smith MM, Qazi M, McFarlane N, Mann A, Ajani OA, Yarascavitch B, Ramaswamy V, Farooq H, Morrissy S, Cao L, Sydorenko N, Baiazitov R, Du W, Sheedy J, Weetall M, Moon YC, Lee CS, Kwiecien JM, Delaney KH, Doble B, Cho YJ, Mitra S, Kaplan D, Taylor MD, Davis TW, Singh SK.

Oncogene. 2019 Mar;38(10):1702-1716. doi: 10.1038/s41388-018-0549-9. Epub 2018 Oct 22.

PMID:
30348991
46.

Magnetic resonance imaging computation of intracardiac flow derangements in heart failure dyssynchrony.

Taylor MD, Kutty S.

Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H10-H12. doi: 10.1152/ajpheart.00676.2018. Epub 2018 Oct 19. No abstract available.

PMID:
30339497
47.

A database of marine larval fish assemblages in Australian temperate and subtropical waters.

Smith JA, Miskiewicz AG, Beckley LE, Everett JD, Garcia V, Gray CA, Holliday D, Jordan AR, Keane J, Lara-Lopez A, Leis JM, Matis PA, Muhling BA, Neira FJ, Richardson AJ, Smith KA, Swadling KM, Syahailatua A, Taylor MD, van Ruth PD, Ward TM, Suthers IM.

Sci Data. 2018 Oct 16;5:180207. doi: 10.1038/sdata.2018.207.

48.

Bioinformatic Strategies for the Genomic and Epigenomic Characterization of Brain Tumors.

Ramaswamy V, Taylor MD.

Methods Mol Biol. 2019;1869:37-56. doi: 10.1007/978-1-4939-8805-1_4.

PMID:
30324512
49.

Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.

Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, Li G, Wechsler-Reya RJ, Reimand J, Cho YJ, Taylor MD, Weissman IL, Mitra SS, Cheshier SH.

Nat Commun. 2018 Oct 8;9(1):4121. doi: 10.1038/s41467-018-06564-9. Erratum in: Nat Commun. 2018 Nov 2;9(1):4651.

50.

Evaluation of pulmonary artery stenosis in congenital heart disease patients using functional diagnostic parameters: An in vitro study.

D'Souza GA, Banerjee RK, Taylor MD.

J Biomech. 2018 Nov 16;81:58-67. doi: 10.1016/j.jbiomech.2018.09.014. Epub 2018 Sep 15.

PMID:
30293825

Supplemental Content

Loading ...
Support Center